How to Choose Between PacBio and Nanopore for Your Long-Read Sequencing Project: An Error-Aware Decision Framework

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-21

Key Takeaways

• PacBio HiFi reads offer high accuracy with randomly distributed errors, simplifying downstream analysis for applications like de novo assembly and variant calling by enabling the use of standard bioinformatics tools.
• Oxford Nanopore Technologies (ONT) provides flexibility with re-basecalling capabilities and ultra-long reads, which are advantageous for spanning complex structural variants and repetitive regions, but require analysis tools that account for systematic errors in homopolymers and sequence context.
• For metagenomics, ONT's lower cost per sample and higher throughput make it competitive, especially with modern basecallers and assemblers like myloasm, potentially yielding more complete circular genomes than PacBio HiFi for the same budget.
• Transcript isoform quantification can be accurately performed by both platforms, with ONT offering cost-effectiveness and higher throughput for larger experimental designs, while PacBio HiFi provides highly accurate full-length transcripts.
• Epigenetic modification detection differs: PacBio uses kinetic signatures from polymerase incorporation, while ONT directly measures electrical current changes from native DNA, with ONT offering the advantage of preserving modification states without amplification.
• Platform selection necessitates a detailed cost analysis beyond per-base price, including instrument access, library preparation, compute resources for basecalling (especially GPU for ONT), and data storage, alongside a pilot validation run using representative samples and defined analysis pipelines.

Long-read sequencing platforms from Pacific Biosciences (PacBio) and Oxford Nanopore Technologies (ONT) produce data that can resolve genomic features beyond the reach of short-read instruments, but the two platforms differ substantially in error profiles, throughput, cost structure, and basecalling flexibility. This article provides a structured decision framework for researchers who must match platform choice to specific project goals such as de novo assembly, variant calling, epigenetics, metagenomics, or transcript isoform quantification. The framework centers on error type awareness instead of platform brand loyalty, because the biological question determines which error characteristics are tolerable and which are disqualifying.

The decision between PacBio and ONT involves multiple subdecisions: which instrument model, which chemistry version, which basecaller, which coverage depth, and which downstream analysis pipeline. Each of these subdecisions interacts with the others, and the optimal combination depends on the research question, the genome complexity, the available compute resources, and the budget. This article walks through the evidence-based considerations for each of these subdecisions and provides a scoring matrix that researchers can adapt to their specific context.

At a Glance: Platform Comparison for Common Project Types

The following table summarizes the key decision factors for common long-read sequencing applications. The ratings reflect the current evidence base and should be adjusted based on specific instrument models, chemistry versions, and local conditions.

The table above condenses the decision space, but each row hides substantial complexity. The sections that follow unpack the evidence behind these ratings and provide the analytical framework for making the choice in your specific context.

Understanding Error Profiles: The Foundation of Platform Choice

The most consequential difference between PacBio and ONT lies in how errors manifest in the resulting sequence data. Short-read platforms produce highly accurate reads with rare, randomly distributed errors. Long-read platforms historically produced reads with higher error rates, but the error structure differs fundamentally between PacBio and ONT, and modern chemistry versions have narrowed the accuracy gap considerably.

PacBio Error Characteristics

PacBio sequencing uses a circular consensus sequencing approach. The polymerase reads the same DNA template multiple times, and the instrument generates a consensus sequence from these repeated passes. The resulting HiFi reads achieve high per-read accuracy because random errors average out across the multiple passes. The error profile of HiFi reads is characterized by low overall error rates with errors distributed approximately randomly across the read.

The key practical consequence of this error structure is that assembly algorithms and variant callers designed for high-accuracy inputs perform well with HiFi data. The error rate is low enough that most analysis tools can treat HiFi reads similarly to short reads, albeit with the substantial advantage of length. This simplifies the bioinformatics pipeline and reduces the need for error correction steps that add computational cost and complexity.

ONT Error Characteristics

Oxford Nanopore sequencing measures changes in electrical current as DNA passes through a protein nanopore. The basecaller translates these current signals into nucleotide sequences using neural network models. The error profile of ONT data depends heavily on the pore version, the chemistry, and the basecalling model. Modern R10.4 pores with current basecallers produce error rates that approach those of HiFi reads for many applications, but the error structure remains different.

ONT errors are not purely random. They include systematic errors in homopolymer regions, where the electrical signal must distinguish between runs of the same nucleotide. Basecallers have improved substantially in handling homopolymers, but these regions remain more challenging for ONT than for PacBio. Additionally, ONT error rates can vary by sequence context, with certain motifs proving more difficult than others.

The practical consequence of ONT error structure is that downstream analysis tools must account for the specific error model. Many modern tools have been developed or updated to handle ONT data, and the evidence base for their performance continues to grow. The choice of basecaller and the quality filtering thresholds have outsized effects on downstream results.

Basecalling Flexibility as a Decision Factor

One of the most distinctive features of ONT sequencing is that basecalling occurs after sequencing, and the raw signal data can be re-basecalled as improved models become available. This means that a dataset sequenced with an older chemistry can potentially benefit from newer basecalling models without resequencing. The raw signal data, stored in FAST5 or POD5 format, retains the full information content of the electrical measurements.

PacBio data does not offer this same flexibility. The circular consensus sequencing process generates the consensus sequence during the run, and while downstream polishing can improve assemblies, the fundamental read accuracy is fixed at the time of sequencing. Researchers who anticipate rapid improvements in basecalling accuracy may find ONT's re-basecalling capability advantageous, particularly for projects where the sequencing data will be analyzed repeatedly over time.

The tradeoff is that ONT's flexibility requires researchers to manage raw signal data storage, which consumes substantial disk space. The decision to retain raw signals for potential re-basecalling must be weighed against storage costs and the likelihood that improved basecallers will meaningfully change results.

Matching Platform to Research Question

The choice between PacBio and ONT should follow from the specific biological question, not from general preferences or institutional availability. Different research questions impose different constraints on error tolerance, read length, throughput, and cost.

De Novo Genome Assembly

For de novo assembly, the primary goals are contiguity and accuracy. Contiguity depends on read length and the ability to span repetitive regions. Accuracy depends on the per-base error rate and the effectiveness of assembly and polishing algorithms.

PacBio HiFi reads provide a strong combination of length and accuracy for assembly. The low error rate means that assembly graphs are relatively clean, and the resulting contigs require minimal polishing. The evidence from metagenome assembly studies shows that HiFi reads can produce complete circular genomes from complex microbial communities, although the cost per sample can be substantial.

ONT reads with modern R10.4 pores and current basecallers have become competitive for assembly. Recent assembler developments have specifically targeted modern long-read error profiles, and the evidence shows that ONT data can produce assemblies comparable to HiFi for many samples. The key advantage of ONT for assembly is the potential for ultra-long reads, which can span repetitive regions that defeat shorter reads regardless of their accuracy.

The decision for assembly projects should consider the genome complexity. For genomes with extensive repetitive content, the ability to generate ultra-long ONT reads may outweigh the accuracy advantage of HiFi. For genomes with moderate complexity, HiFi accuracy simplifies the assembly process and reduces the need for specialized assembly parameters.

Structural Variant Detection

Structural variants range from small insertions and deletions to large chromosomal rearrangements. The detection of these variants depends on read length to span breakpoints and read accuracy to map reads uniquely to the reference genome.

PacBio HiFi reads excel at precise breakpoint resolution because their low error rate allows for accurate local alignment. The tradeoff is that HiFi read lengths, typically 10 to 25 kilobases, may not span the largest structural variants or complex rearrangements.

ONT reads can be substantially longer, with some reads exceeding 100 kilobases under optimal conditions. These ultra-long reads can span entire structural variant regions, providing evidence for variant structure that shorter reads cannot capture. The higher error rate of ONT reads requires variant callers that model the error profile, but the evidence base for such callers has strengthened considerably.

The decision for structural variant projects should weigh the importance of breakpoint precision against the importance of spanning large variants. Projects focused on small to medium structural variants may prefer HiFi accuracy. Projects targeting large rearrangements or complex regions may benefit from ONT read length.

Metagenomics and Microbial Community Analysis

Metagenomics presents unique challenges because the sample contains multiple organisms at varying abundances, and the assembly must reconstruct individual genomes from a mixed pool of reads. The evidence from recent benchmarking studies shows that both platforms can produce high-quality metagenome assemblies, but the cost and throughput characteristics differ.

The LEMMIv2 benchmarking framework provides a systematic comparison of metagenomic profilers and includes support for long-read applications. This resource allows researchers to evaluate tools against standardized benchmarks instead of relying on individual study claims. The framework's catalogue of evaluated tools helps researchers select appropriate analysis methods for their specific metagenomic questions.

Recent assembler developments have specifically targeted modern long-read data. The myloasm assembler, designed for PacBio HiFi and ONT R10.4 reads, demonstrates that ONT data can achieve assembly results comparable to HiFi when the assembler accounts for the error profile. In a jointly sequenced gut metagenome, myloasm with ONT data assembled more complete circular genomes than any assembler with HiFi data. This evidence suggests that the platform choice for metagenomics should consider the specific assembler and analysis pipeline instead of assuming HiFi superiority.

The cost structure differs substantially between platforms for metagenomics. ONT offers lower per-sample costs and higher throughput, making it feasible to sequence more samples or achieve deeper coverage for the same budget. PacBio HiFi offers higher per-read accuracy but at a higher cost per base. For metagenomic projects where the goal is recovering multiple genomes from each sample, the cost per assembled genome becomes the relevant metric, and ONT often performs favorably.

Transcript Isoform Quantification

Long-read sequencing enables the direct observation of full-length transcript isoforms, which short-read technologies cannot achieve. The evidence from recent work on long-read transcript quantification shows that accurate and affordable isoform quantification is possible with ONT data, and that exome capture can improve the results.

The lr-kallisto method adapts the kallisto quantification approach for long-read technologies. The evidence demonstrates that fast and accurate quantification of long-read data is achievable, addressing the bioinformatic challenges posed by isoform complexity and genetic variation. This development makes long-read transcriptomics more accessible for routine use.

For transcript quantification projects, the choice between PacBio and ONT depends on the required accuracy and the number of samples. PacBio HiFi reads provide highly accurate full-length transcripts, which simplifies isoform identification. ONT reads offer lower cost per sample and higher throughput, enabling larger experimental designs. The evidence that ONT data can support accurate quantification suggests that cost considerations may drive platform choice for many transcriptomics projects.

Epigenetic Modification Detection

Both platforms can detect epigenetic modifications, but through different mechanisms. PacBio detects modifications through kinetic signatures, measuring the time polymerase takes to incorporate nucleotides at modified positions. ONT detects modifications through the electrical current signal, which differs when modified bases pass through the pore.

The choice between platforms for epigenetics depends on the specific modifications of interest and the basecalling models available. ONT offers the advantage of sequencing native DNA without amplification, preserving the original modification state. PacBio HiFi sequencing typically involves amplification steps that can affect modification detection, although specialized protocols exist.

The basecalling model availability is a practical consideration. ONT basecallers can be trained or configured to detect specific modifications, and the raw signal data can be re-analyzed as new models become available. PacBio modification detection depends on the kinetic information captured during sequencing, which is fixed at the time of the run.

Cost Analysis: Total Project Economics

The cost comparison between PacBio and ONT extends beyond the per-base sequencing price. The total project cost includes instrument access, library preparation, sequencing consumables, compute resources for basecalling and analysis, and personnel time for troubleshooting and optimization.

Instrument and Access Costs

PacBio instruments range from the smaller Sequel systems to the larger Revio platforms. The capital cost of these instruments is substantial, and many researchers access them through core facilities or service providers. ONT offers a range of instruments from the portable MinION to the high-throughput PromethION, with corresponding differences in capital cost and throughput.

The portable nature of some ONT instruments enables sequencing in field settings or resource-limited laboratories where PacBio instruments are not available. This accessibility consideration may be decisive for projects in locations without established sequencing infrastructure.

Per-Sample and Per-Base Costs

The per-base cost of sequencing has decreased for both platforms with each new chemistry release. The relevant comparison depends on the required coverage depth and the number of samples. For projects requiring deep coverage of a single genome, the per-base cost difference may be less important than the accuracy characteristics. For projects involving many samples at lower coverage, the per-sample cost becomes the dominant factor.

ONT generally offers lower per-base costs than PacBio, particularly at higher throughput levels. This cost advantage must be weighed against the potential need for additional sequencing depth to compensate for higher error rates, although modern ONT chemistry has narrowed this gap.

Compute and Storage Costs

The compute requirements differ substantially between platforms. ONT basecalling requires GPU resources, particularly for real-time basecalling with the latest models. The raw signal data consumes substantial storage, and the decision to retain this data for potential re-basecalling adds to the storage burden.

PacBio HiFi sequencing generates consensus reads during the run, reducing the need for extensive post-processing compute. The downstream analysis of HiFi data is generally less compute-intensive than ONT data because the error rate is lower and standard tools can be used without extensive parameter tuning.

The total cost of compute and storage should be included in the platform comparison. A project that appears cost-effective on a per-base basis may become more expensive when compute and storage requirements are included.

Practical Workflow Considerations

The choice between PacBio and ONT affects the entire workflow from library preparation through data analysis. Understanding these workflow differences helps researchers plan their projects and allocate resources appropriately.

Library Preparation

PacBio library preparation involves shearing DNA to the desired fragment size, repairing ends, and ligating adapters. The circular consensus sequencing process requires the library to form circular templates, and the read length is determined by the polymerase read length and the number of passes.

ONT library preparation involves attaching adapters that enable the DNA to interact with the nanopore. The library preparation can be completed in under an hour for some protocols, enabling rapid turnaround from sample to data. The read length depends on the DNA quality and the library preparation method, with protocols available for ultra-long reads.

The choice of library preparation method affects the read length distribution and the error profile. Researchers should consider the DNA quality of their samples, as degraded DNA will limit read length regardless of platform.

Sequencing Run Management

PacBio sequencing runs are typically planned in advance, with defined run times and throughput expectations. The instrument operates autonomously during the run, and the data becomes available after the run completes.

ONT sequencing can be monitored in real time, with basecalled reads appearing as the run progresses. This real-time capability enables adaptive sequencing, where the researcher can decide to stop the run once sufficient data has been collected or to extend the run for additional coverage. The real-time nature of ONT sequencing also enables rapid decisions about data quality, allowing researchers to restart or adjust runs before completing the full planned duration.

Basecalling and Quality Control

Basecalling is a critical step for ONT data, and the choice of basecaller and model parameters affects the downstream results. The basecalling can be performed in real time during the run or post-run using the raw signal data. The quality scores generated by the basecaller provide the basis for read filtering and downstream analysis decisions.

PacBio HiFi reads include quality scores from the consensus process, and these scores can be used for read filtering. The quality score distribution is generally narrow, with most reads achieving high quality, which simplifies the filtering step.

Quality control for both platforms should include assessment of read length distribution, quality score distribution, and coverage depth. The specific thresholds for these metrics depend on the downstream application and should be established before the sequencing run.

Analysis Pipelines and Tool Selection

The choice of analysis tools depends on the platform and the research question. The bioinformatics ecosystem for long-read data has matured substantially, with tools available for assembly, variant calling, metagenomics, transcriptomics, and epigenetics.

Assembly Tools

The assembler choice has a substantial effect on the quality of the final assembly. Modern assemblers have been developed specifically for long-read data, and their performance depends on the error profile of the input reads.

For PacBio HiFi data, assemblers such as hifiasm and HiCanu produce high-quality assemblies with minimal polishing. The low error rate of HiFi reads simplifies the assembly graph and reduces the need for error correction steps.

For ONT data, assemblers such as Flye and Raven have been developed to handle the higher error rates and specific error patterns. The recent development of myloasm demonstrates that assemblers designed for modern ONT R10.4 reads can achieve results comparable to HiFi assemblies. The choice of assembler should be based on the specific error profile of the data and the characteristics of the genome being assembled.

Variant Calling Tools

Variant calling from long-read data requires tools that model the error profile of the platform. For PacBio HiFi data, variant callers such as DeepVariant and Clair3 achieve high accuracy because the error rate is low and the error distribution is approximately random.

For ONT data, variant callers must account for the systematic errors in homopolymer regions and the context-dependent error rates. Tools such as Clair3 and Medaka have been developed specifically for ONT data and incorporate the error model into their calling algorithm.

The choice of variant caller should be validated on a subset of the data before running the full analysis. The validation should include comparison against known variants or orthogonal methods to ensure the caller performs as expected.

Metagenomic Analysis Tools

Metagenomic analysis involves multiple steps, including taxonomic profiling, assembly, binning, and functional annotation. The choice of tools for each step depends on the platform and the research question.

The LEMMIv2 benchmarking framework provides a systematic approach to evaluating metagenomic profilers. The framework includes support for long-read applications and provides a catalogue of evaluated tools. Researchers can use this resource to select tools that have been validated against standardized benchmarks.

For metagenome assembly, the choice of assembler depends on the platform and the complexity of the microbial community. The myloasm assembler demonstrates that modern long-read assemblers can achieve high-quality results with both HiFi and ONT data, with the specific performance depending on the community composition and sequencing depth.

Transcriptomics Tools

Long-read transcriptomics requires tools that can map reads to the transcriptome, identify isoforms, and quantify expression levels. The lr-kallisto method demonstrates that accurate quantification is possible with ONT data, and the method's adaptation of the kallisto approach provides a computationally efficient solution.

The choice of transcriptomics tools should consider the specific goals of the project. Projects focused on isoform discovery may require different tools than projects focused on differential expression. The evidence base for long-read transcriptomics tools continues to grow, and researchers should consult recent literature and benchmarking studies when selecting tools.

Training and Reproducibility Resources

The complexity of long-read analysis pipelines requires researchers to maintain current skills and follow reproducible practices. The Galaxy Training Network provides accessible workflow training and analysis tutorials that cover long-read data processing. The nf-core documentation describes community pipeline standards for reproducible bioinformatics workflows, which can be applied to long-read analysis. The Bioconductor project offers packages for genomic analysis with documented installation and usage procedures. The EMBL-EBI training portal provides learning pathways for bioinformatics data resources and practical analysis education. Foundational computing skills, including shell, Git, and data management, are covered by The Carpentries lessons. The NCBI data resources provide access to reference sequences, databases, and analysis services that support long-read project validation.

Records and Measurements for Platform Comparison

Systematic record-keeping enables evidence-based platform decisions. The following measurements should be recorded for each sequencing run and used to inform future platform choices.

Run-Level Metrics

For each sequencing run, record the platform, instrument model, chemistry version, basecaller version, and basecalling model. These parameters affect the error profile and should be documented for reproducibility.

Record the total yield in bases, the read length N50, the read quality distribution, and the coverage depth achieved. These metrics determine whether the run met the project requirements and provide the basis for comparing runs across platforms.

For ONT runs, record the pore version and the number of active pores over the run duration. Pore performance affects throughput and should be monitored for quality control.

Error Profile Assessment

For projects where error profile is critical, assess the error rate and error structure using a reference genome or a subset of reads mapped to a known sequence. Record the overall error rate, the error rate in homopolymer regions, and the distribution of error types (substitutions, insertions, deletions).

The error profile assessment should be repeated when new chemistry versions or basecallers become available, as the error characteristics may change substantially.

Cost Tracking

Record the total cost of each sequencing run, including library preparation, sequencing consumables, compute resources, and personnel time. Track the cost per gigabase and the cost per sample to enable comparison across platforms and projects.

The cost tracking should include the compute and storage costs for basecalling and analysis, as these costs can be substantial for ONT data.

Common Failure Patterns and Troubleshooting

Understanding common failure patterns helps researchers anticipate problems and respond effectively when they occur.

Insufficient Coverage Depth

The most common cause of failed long-read projects is insufficient coverage depth. The required depth depends on the application, the genome complexity, and the platform error rate. Projects that underestimate the required depth may produce assemblies with gaps or variant calls with low confidence.

The solution is to calculate the required coverage before sequencing and to monitor coverage during the run. For ONT runs, the real-time data availability enables coverage monitoring and run extension if needed.

Read Length Degradation

Read length degradation occurs when DNA quality is poor or when library preparation introduces damage. The result is a read length distribution that is shorter than expected, reducing the ability to span repetitive regions and resolve structural variants.

The solution is to assess DNA quality before library preparation and to use protocols optimized for the sample type. For degraded samples, the choice of platform may be affected, as the read length advantage of ONT may not be realized if the input DNA is fragmented.

Basecalling Model Mismatch

For ONT data, the choice of basecalling model must match the pore version and chemistry. Using an outdated model with new chemistry produces suboptimal accuracy. The solution is to verify the basecalling model before starting the run and to update models as new versions become available.

Assembly Parameter Mismatch

Assembly tools have parameters that must be adjusted for the specific error profile of the data. Using parameters optimized for HiFi data with ONT data, or vice versa, produces poor assemblies. The solution is to use the recommended parameters for the specific platform and to test multiple parameter sets on a subset of the data.

Limitations and Interpretation Boundaries

The choice between PacBio and ONT involves tradeoffs that cannot be fully resolved by any single framework. The following limitations should be considered when interpreting the evidence and making platform decisions.

Rapid Technology Evolution

Both platforms are evolving rapidly, with new chemistry versions, basecallers, and analysis tools released frequently. The evidence base for platform comparison becomes outdated quickly, and decisions based on current evidence may not apply to future versions.

Researchers should monitor the literature and benchmarking studies for updates and should validate platform performance on their specific samples instead of relying solely on published comparisons.

Sample-Specific Effects

The performance of both platforms depends on the specific sample characteristics, including GC content, repeat content, and DNA quality. A platform that performs well on one sample type may perform poorly on another. The decision framework should include a pilot run on representative samples before committing to a large-scale project.

Analysis Tool Dependence

The platform choice interacts with the analysis tool choice, and the optimal combination depends on both. A platform that performs poorly with one assembler may perform well with another. The decision framework should consider the available analysis tools and their performance with each platform.

Synthetic DNA Construction Context

The ability to construct long complex synthetic DNA sequences currently lags behind the ability to sequence and edit DNA. The Sidewinder assembly technique demonstrates that new approaches to DNA construction can separate assembly guidance information from the final sequence, enabling high-fidelity assembly of complex sequences. Researchers planning projects that combine long-read sequencing with synthetic DNA construction should consider how platform choice affects their ability to validate assembled constructs.

Professional Escalation Criteria

Certain situations warrant escalation to specialized expertise or alternative approaches. The following criteria indicate when the standard decision framework may be insufficient.

Unusual Genome Complexity

Genomes with extreme repeat content, high heterozygosity, or polyploidy may require specialized approaches beyond the standard platform choice. The evidence from polyploid haplotype reconstruction shows that specialized algorithms can address these challenges, but the platform and tool choices require careful consideration.

The nTChap method for polyploid haplotype reconstruction demonstrates that long-read data can support accurate phasing in complex genomes. Researchers working with polyploid genomes should consult specialists in this area before selecting platforms and tools.

Regulatory or Clinical Applications

Projects with regulatory or clinical implications require validated workflows and documented performance characteristics. The platform choice may be constrained by regulatory requirements or by the need for specific quality metrics. Researchers should consult with regulatory experts and follow established validation protocols.

Unusual Sample Types

Samples with extreme GC content, high degradation, or contamination may require specialized library preparation protocols or alternative sequencing approaches. The standard platform comparison may not apply to these samples, and consultation with sequencing facility staff is recommended.

Building a Platform-Specific Validation Protocol Before Full-Scale Sequencing

A pilot validation run is the single most reliable way to resolve the PacBio versus ONT decision for your specific samples, yet many researchers skip this step and commit to a platform based on published benchmarks or institutional availability. Published comparisons provide useful baselines, but they cannot account for your sample type, your DNA extraction method, your analysis pipeline, or your quality thresholds. A structured validation protocol generates the evidence you need to make the final platform decision with confidence.

Designing the Pilot Validation Run

The pilot should include representative samples from your actual project, not idealized control DNA. If your project involves multiple sample types, include at least one sample from each major category. For metagenomic projects, include a sample with community complexity similar to your target samples. For clinical or environmental samples, use the same DNA extraction method you will use for the full project, because extraction method affects DNA length, purity, and modification state.

Sequence the same samples on both platforms if your budget allows. This direct comparison eliminates the confounding effects of sample variation and provides the clearest evidence for platform choice. If dual-platform sequencing is not feasible, sequence your samples on the platform you are considering and compare the results against a reference genome or against short-read data from the same samples.

The pilot should include at least the following components:

• Two to three representative samples covering the range of expected sample quality
• The same library preparation protocols you plan to use for the full project
• The current chemistry versions and basecalling models for each platform
• Coverage depth sufficient to assess error profiles, typically 20x to 30x for a small genome or a targeted region
• A defined set of downstream analysis steps that mirror your full project pipeline

Metrics to Collect During the Pilot

The pilot generates the data you need to populate the decision matrix with project-specific values instead of generic estimates. Collect the following metrics for each platform and sample combination:

Read length distribution. Record the N50, the mean read length, and the fraction of reads above your minimum useful length threshold. For assembly projects, the fraction of reads above 20 kilobases matters more than the mean. For variant detection, the fraction of reads spanning your target variant regions matters most.

Error rate and error structure. Map a subset of reads to a reference genome if one is available, or use a closely related genome. Record the overall error rate, the substitution rate, the insertion rate, and the deletion rate. Pay particular attention to homopolymer regions and tandem repeats, where the two platforms differ most.

Coverage uniformity. Assess how evenly reads cover the genome or target regions. Some regions may be underrepresented due to GC content, secondary structure, or methylation. The coverage uniformity affects the depth required for confident variant calls or complete assemblies.

Basecalling quality scores. Record the quality score distribution and the relationship between quality scores and actual error rates. Quality scores that overestimate accuracy can lead to under-filtering and downstream errors.

Compute time and resource usage. Record the time and resources required for basecalling, quality filtering, and the first downstream analysis step. This information feeds into the total cost calculation and helps you plan compute infrastructure for the full project.

Analyzing the Pilot Results

The pilot analysis should answer three questions. First, does each platform produce data that meets your minimum quality thresholds? Second, which platform produces better results for your specific downstream application? Third, what is the cost per unit of useful output for each platform?

For assembly projects, assemble the pilot data with your chosen assembler and assess the assembly statistics. Record the number of contigs, the N50, the total assembled length, and the completeness using BUSCO or a similar metric. Compare the assemblies from each platform and identify any regions that one platform fails to assemble.

For variant calling projects, call variants on the pilot data and compare against known variants or against short-read variant calls from the same samples. Record the precision and recall for each platform. Pay particular attention to the variant types that matter for your project, such as structural variants, small indels, or single nucleotide variants in difficult regions.

For metagenomic projects, run your taxonomic profiling and assembly pipeline on the pilot data. Record the number of species detected, the completeness of assembled genomes, and the accuracy of abundance estimates. The LEMMIv2 benchmarking framework provides a structured approach to evaluating metagenomic profilers and can be applied to your pilot data.

For transcriptomic projects, run your isoform detection and quantification pipeline on the pilot data. Record the number of isoforms detected, the accuracy of quantification against a reference or against orthogonal methods, and the reproducibility across technical replicates. The lr-kallisto method demonstrates that accurate quantification is achievable with ONT data and provides a reference point for expected performance.

Making the Final Platform Decision

The pilot results should feed directly into the decision matrix. Assign weights to each criterion based on your project priorities, then score each platform based on the pilot evidence. The platform with the higher weighted score is the better choice for your specific project.

The decision should also account for the cost per unit of useful output, beyond the per-base cost. Calculate the total cost of the pilot run for each platform, including library preparation, sequencing, compute, and personnel time. Divide by the number of useful bases or the number of assembled genomes or the number of confident variant calls to obtain the cost per unit of useful output. This metric often differs substantially from the advertised per-base cost.

Recording the Validation Results

Document the pilot results in a structured format that can be referenced throughout the project. Include the platform, chemistry version, basecaller version, sample identifiers, and all metrics collected. This documentation serves multiple purposes: it provides the evidence for your platform choice, it establishes baseline expectations for the full project, and it enables troubleshooting if the full project produces unexpected results.

The Galaxy Training Network provides tutorials on reproducible analysis workflows that can help you structure your validation protocol. The nf-core documentation describes community standards for reproducible pipelines that can be applied to the validation analysis. The Bioconductor project offers packages for genomic analysis with documented installation and usage procedures that support reproducible validation.

Common Pilot Validation Pitfalls

Several common mistakes undermine the value of pilot validation. Using idealized control DNA instead of representative samples produces results that do not transfer to the full project. Skipping the downstream analysis and evaluating only read-level metrics misses the interactions between platform error profiles and analysis tools. Comparing platforms at different coverage depths confounds the platform effect with the coverage effect. Failing to record compute time and resource usage leaves out a major component of the total cost comparison.

Another common pitfall is treating the pilot as a one-time event. If you change chemistry versions, basecallers, or analysis tools during the project, the pilot results may no longer apply. Re-run a small validation experiment when major changes occur, particularly for ONT data where basecalling model updates can substantially change error profiles.

When the Pilot Reveals No Clear Winner

Some projects will produce comparable results on both platforms, with the decision resting on cost, throughput, or operational factors instead of data quality. In these cases, the decision should consider the full project context, including the number of samples, the timeline, the available compute infrastructure, and the expertise of the analysis team.

The pilot may also reveal that neither platform meets your requirements with the current chemistry and tools. In this case, consider whether the project goals can be adjusted, whether additional coverage would help, or whether a hybrid approach using both platforms is warranted. Some projects benefit from using ONT for ultra-long reads to span complex regions and PacBio HiFi for accurate base-level resolution, with the two datasets combined in the assembly or variant calling step.

Frequently Asked Questions

What is the most important factor in choosing between PacBio and Nanopore?

The most important factor is the error profile of the data relative to your specific research question. PacBio HiFi reads have lower overall error rates with approximately random error distribution, which simplifies downstream analysis. ONT reads have higher error rates with systematic components, but modern R10.4 chemistry and basecallers have narrowed the gap substantially. The decision should weigh the accuracy requirements of your application against the cost, throughput, and read length advantages of each platform.

Can Nanopore data achieve assembly quality comparable to PacBio HiFi?

Yes, with modern chemistry and appropriate assemblers. The myloasm assembler was specifically designed for modern long reads including ONT R10.4 and PacBio HiFi, and the evidence shows that ONT data can produce assemblies comparable to HiFi when the assembler accounts for the error profile. In a jointly sequenced gut metagenome, myloasm with ONT data assembled more complete circular genomes than any assembler with HiFi data.

How does basecalling affect Nanopore data quality?

Basecalling is the process of converting the raw electrical signal into nucleotide sequences, and the choice of basecaller and model has a substantial effect on accuracy. The basecalling can be performed in real time during the run or post-run using the raw signal data. The raw signal data can be re-basecalled as improved models become available, providing flexibility that PacBio does not offer.

What coverage depth is recommended for long-read assembly?

The recommended coverage depends on the genome complexity and the platform error rate. For small genomes with moderate complexity, 30x to 50x coverage is typically sufficient for both platforms. More complex genomes or metagenomic samples may require substantially higher coverage. The specific requirement should be determined through pilot runs and consultation with the analysis pipeline.

How do costs compare between PacBio and Nanopore?

ONT generally offers lower per-base costs than PacBio, particularly at higher throughput levels. However, the total project cost includes library preparation, compute resources for basecalling and analysis, and storage for raw signal data. The cost comparison should include all of these components and should be evaluated on a per-sample or per-assembled-genome basis instead of per-base alone.

Can both platforms detect epigenetic modifications?

Yes, both platforms can detect epigenetic modifications, but through different mechanisms. PacBio detects modifications through kinetic signatures during polymerase incorporation, while ONT detects modifications through changes in the electrical current as modified bases pass through the pore. ONT sequences native DNA without amplification, which preserves the original modification state, and the raw signal data can be re-analyzed as new modification detection models become available.

What are the main bioinformatics challenges for long-read data?

The main challenges are managing the error profile, handling the data volume, and selecting appropriate analysis tools. ONT data requires basecalling and error-aware analysis tools, while PacBio HiFi data can often be analyzed with standard tools. The compute and storage requirements for ONT raw signal data can be substantial, and the choice of analysis tools should be validated on the specific data before full-scale analysis.

How should I validate my platform choice before committing to a large project?

Run a pilot experiment with representative samples on both platforms, if feasible. Assess the read length distribution, error profile, and coverage depth for each platform. Run the downstream analysis pipeline on the pilot data and compare the results against known variants or reference assemblies. Use the pilot results to estimate the required coverage and total cost for the full project.

Related Bioinformatics Guides

• How to Choose a Long-Read Sequencing Platform: PacBio vs Oxford Nanopore
• Long-Read Metagenome Assembly: Overcoming Challenges with Nanopore and PacBio Data
• Long-Read Sequencing Technologies: PacBio and Oxford Nanopore
• Long-Read Sequencing Cost and Market: What to Expect
• Long-Read Sequencing for Isoform Quantification: Challenges and Solutions

Related Clinical & Scientific Guides

• A Practical Guide to Detecting Antimicrobial Resistance Genes in Shotgun Metagenomic Data
• Computational Immunology: Modeling the Immune System
• How to Set Hard Filters for Germline Variant Calling: A Practical Guide to GATK Best Practices

References and Further Reading

• NCBI Data Resources. National Center for Biotechnology Information.
• EMBL-EBI Training. European Bioinformatics Institute.
• Bioconductor. Bioconductor Project.
• Galaxy Training Network. Galaxy Project.
• nf-core Documentation. nf-core.
• The Carpentries Lessons. The Carpentries.
• Long-read sequencing transcriptome quantification with lr-kallisto.. 2025.
• LEMMIv2: benchmarking framework for metagenomic and 16S amplicon profilers with a catalogue of evaluated tools.. 2026.
• High-resolution metagenome assembly for modern long reads with myloasm.. 2026.
• nTChap: an accurate method for polyploid haplotype reconstruction.. 2026.
• Construction of complex and diverse DNA sequences using DNA three-way junctions.. 2026.

This article is educational and does not replace validated analysis plans, institutional policy, clinical interpretation, or specialist review.